79 related articles for article (PubMed ID: 38470366)
1. Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy.
Singh D; Tewari M; Singh S; Narayan G
Future Oncol; 2021 Feb; 17(5):581-596. PubMed ID: 33401962
[TBL] [Abstract][Full Text] [Related]
2. Insight into the role of TRAIL in liver diseases.
Jiang W; Wu DB; Fu SY; Chen EQ; Tang H; Zhou TY
Biomed Pharmacother; 2019 Feb; 110():641-645. PubMed ID: 30544063
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophage-based particles carrying the TNF-related apoptosis-inducing ligand (TRAIL) gene for targeted delivery in hepatocellular carcinoma.
Sittiju P; Wudtiwai B; Chongchai A; Hajitou A; Kongtawelert P; Pothacharoen P; Suwan K
Nanoscale; 2024 Mar; 16(13):6603-6617. PubMed ID: 38470366
[TBL] [Abstract][Full Text] [Related]
4. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.
Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG
World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
Koehler BC; Urbanik T; Vick B; Boger RJ; Heeger S; Galle PR; Schuchmann M; Schulze-Bergkamen H
World J Gastroenterol; 2009 Dec; 15(47):5924-35. PubMed ID: 20014456
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
8. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
Yang JF; Cao JG; Tian L; Liu F
Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
[TBL] [Abstract][Full Text] [Related]
9. Transmorphic phage-guided systemic delivery of TNFα gene for the treatment of human pediatric medulloblastoma.
Al-Bahrani M; Asavarut P; Waramit S; Suwan K; Hajitou A
FASEB J; 2023 Jul; 37(7):e23038. PubMed ID: 37331004
[TBL] [Abstract][Full Text] [Related]
10. Integrins in human hepatocellular carcinoma tumorigenesis and therapy.
Gao Q; Sun Z; Fang D
Chin Med J (Engl); 2023 Feb; 136(3):253-268. PubMed ID: 36848180
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options in hepatocellular carcinoma: a comprehensive review.
Suresh D; Srinivas AN; Prashant A; Harikumar KB; Kumar DP
Clin Exp Med; 2023 Oct; 23(6):1901-1916. PubMed ID: 36780119
[TBL] [Abstract][Full Text] [Related]
12. Phage therapy: From biological mechanisms to future directions.
Strathdee SA; Hatfull GF; Mutalik VK; Schooley RT
Cell; 2023 Jan; 186(1):17-31. PubMed ID: 36608652
[TBL] [Abstract][Full Text] [Related]
13. Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries.
Montinaro A; Walczak H
Cell Death Differ; 2023 Feb; 30(2):237-249. PubMed ID: 36195672
[TBL] [Abstract][Full Text] [Related]
14. 3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies.
Shi H; Rath EM; Lin RCY; Sarun KH; Clarke CJ; McCaughan BC; Ke H; Linton A; Lee K; Klebe S; Maitz J; Song K; Wang Y; Kao S; Cheng YY
Front Oncol; 2022; 12():973576. PubMed ID: 36091141
[TBL] [Abstract][Full Text] [Related]
15. Systemically targeted cancer immunotherapy and gene delivery using transmorphic particles.
Asavarut P; Waramit S; Suwan K; Marais GJK; Chongchai A; Benjathummarak S; Al-Bahrani M; Vila-Gomez P; Williams M; Kongtawelert P; Yata T; Hajitou A
EMBO Mol Med; 2022 Aug; 14(8):e15418. PubMed ID: 35758207
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
